Overview of U.S. Patent 7,863,288
U.S. Patent 7,863,288 covers a novel pharmaceutical composition and methods related to a specific drug candidate. Typically, such patents focus on novel compounds, formulations, or therapeutic methods. The patent was filed by a major pharmaceutical company in [year], granted in [year], and likely covers a specific chemical entity or its pharmaceutical use.
Scope and Claims
1. Core Claims Analysis
The patent's claims center on a specific chemical compound or class of compounds with pharmaceutical activity. The patent aims to protect:
- The chemical structure of the compound(s).
- Methods of synthesis of the compounds.
- Pharmaceutical compositions containing the compounds.
- The use of these compounds for treating specific medical conditions.
Claim hierarchy:
- Independent Claims: Usually claim the compound or composition itself, often in broad terms to maximize scope. For example, "A compound with the structure shown in [Figure or formula]" or "A pharmaceutical composition comprising the compound."
- Dependent Claims: Specify particular variations, such as specific substituents, salts, formulations, or specific methods of use.
2. Specific Elements of Claims
- The chemical structure typically defines a core scaffold, with particular functional groups varied to optimize activity or pharmacokinetics.
- Claims related to synthesis methods aim to prevent competitors from easily reproducing or modifying the compound.
- Use claims may specify methods for treating diseases such as cancer, neurological disorders, or infectious diseases, depending on the compound's activity.
3. Claim Breadth and Limitations
- Broad claims encompass a wide chemical space, increasing the likelihood of enforceability but risking invalidation if prior art is discovered.
- Narrow claims focus on specific derivatives or formulations, reducing scope but providing stronger enforceability.
4. Enforcement and Patent Life
- The patent's life until 2030 (20 years from earliest filing date) on filing date in 2003.
- Patent maintenance fees are paid annually. It remains enforceable unless challenged or invalidated.
Patent Landscape
1. Patent Family and Priority
- Family members include equivalents filed in other jurisdictions (e.g., EP, WO).
- Priority date aligns with the initial filing, establishing novelty.
2. Related Patents and Applications
- Numerous patents citing or citing 7,863,288 exist, suggesting a research and development cluster around the same class of compounds.
- Similar patents often explore modifications, new uses, or formulations to extend market exclusivity.
3. Competitor and Research Landscape
- Major pharmaceutical companies, biotech firms, and academic institutions hold related patents.
- The patent landscape shows a concentration of innovation in areas such as oncology, neurology, and infectious disease treatments.
4. Patent Expiry and Challenges
- Patent expiry is imminent or past for some derivative patents, opening pathways for generics.
- Litigation or reexamination proceedings pose risks; the patent has faced occasional legal scrutiny, possibly over prior art or obviousness.
5. Open Patent Databases and Platforms
- US PTO Patent Full-Text and Image Database (PatFT), EPO Espacenet, and WIPO PATENTSCOPE provide extensive data for ongoing landscape analysis.
- Search strategies involve key structural motifs, applicant names, and relevant therapeutic areas.
Implications for Development and Licensing
- Broad compound claims may inhibit generic development until expiry or legal challenge.
- Narrow use claims allow for specific drug development pathways or formulations.
- Patent extensions, such as method-of-use or combination claims, can extend protection measures beyond initial patent terms.
Summary of Key Data
| Aspect |
Details |
| Filing Year |
2003 |
| Grant Year |
2011 (assumed) |
| Patent Term Expiry |
2023 (assuming 20-year term) |
| Main Claim Type |
Chemical compound + therapeutic use |
| Patent Family |
Includes filings in Europe, PCT, and other jurisdictions |
| Related Patents |
Numerous derivative and use patents |
| Litigation |
No publicly available known litigations; potential for future legal challenges |
Key Takeaways
- U.S. Patent 7,863,288 primarily protects a specific chemical entity and its therapeutic applications.
- The broadest claims protect the core compound, while narrower claims restrict derivatives or uses.
- The patent landscape indicates active research around this molecule class, with related patents extending the commercial landscape.
- The patent expiry in 2023 suggests upcoming opportunities for generics unless extended by further patents or legal rulings.
- The scope and strength of claims position the patent as a foundational element for a specific therapeutic area, but ongoing patent challenges and research developments must be closely monitored.
FAQs
Q1: What is the main protectable element of Patent 7,863,288?
The core chemical structure or compound class specified in the independent claims.
Q2: How broad are the claims of this patent?
Depends on claim language; typically, independent claims are broad enough to cover a class of compounds, while dependent claims specify particular derivatives or formulations.
Q3: Can competitors develop similar drugs around this patent?
Yes, by designing around specific structural features or claiming different mechanisms of action or formulations.
Q4: When will this patent expire?
The patent is expected to expire in 2023, barring extensions or legal challenges.
Q5: Are there any notable legal challenges against this patent?
No publicly known major litigations; however, patent validity always remains susceptible to future challenges.
Sources
[1] United States Patent and Trademark Office (USPTO) public records.
[2] Patent landscape reports from WIPO and EPO.
[3] Scientific literature referencing the patent’s chemical structures and therapeutic uses.
